Pharma Capital
EPIC: AZN
Market: LSE
52-week High/Low: 5,520.00p / 3,996.00p
Sector: Pharma & Biotech
Market Cap: 60,160.32M

AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.

AstraZeneca

www.astrazeneca.com

Interactive graph

col 3
col 4
col 5
col 6

AstraZeneca Timeline

View All

Columns Including AZN

VIEW ALL

Market Reports Including AZN

VIEW ALL

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.